Prof. Mark Emberton, Professor of Urology

Prof. Mark Emberton

Professor of Urology

Prof. Mark Emberton MD FRCS Urol

Professor of Urology

MD FRCS Urol

Prof. Mark Emberton

Professor of Urology MD FRCS Urol

MD FRCS Urol
Prof.Mark Emberton,Urologist

Prof. Emberton is a recommended Professor of urology

Prof. Mark Emberton - Introduction

Prof. Mark Emberton - Introduction

Symptoms of prostate cancer

Symptoms of prostate cancer

Enlarged prostate - Does that mean prostate cancer?

Enlarged prostate - Does that mean prostate cancer?

Can prostate cancer be cured?

Can prostate cancer be cured?

Advice for men who are at risk of prostate cancer

Advice for men who are at risk of prostate cancer

Could I have done anything to prevent prostate cancer?

Could I have done anything to prevent prostate cancer?

How many men die from prostate cancer?

How many men die from prostate cancer?

What is active surveillance?

What is active surveillance?

Prof. Mark Emberton - Research into more accurate diagnosis for prostate cancer

Prof. Mark Emberton - Research into more accurate diagnosis for prostate cancer

Ask an expert about prostate cancer with Prof. Mark Emberton

Ask an expert about prostate cancer with Prof. Mark Emberton

Prof. Mark Emberton - Transforming diagnosis in prostate cancer

Prof. Mark Emberton - Transforming diagnosis in prostate cancer

Prof. Mark Emberton on the role of focal therapy in prostate cancer

Prof. Mark Emberton on the role of focal therapy in prostate cancer

Prof. Mark Emberton on MRI of the prostate - PROSCA 2015

Prof. Mark Emberton on MRI of the prostate - PROSCA 2015

A New Patient Pathway - Prof. Mark Emberton - Part 1

A New Patient Pathway - Prof. Mark Emberton - Part 1

A New Patient Pathway - Prof. Mark Emberton - Part 2

A New Patient Pathway - Prof. Mark Emberton - Part 2

Prof. Emberton explains the NIHR-supported PRECISION trial

Prof. Emberton explains the NIHR-supported PRECISION trial

MRI-based approach to prostate cancer diagnosis

MRI-based approach to prostate cancer diagnosis

Urological cancers: why we need to change

Urological cancers: why we need to change

Good Confident Necrosis with Professor Mark Emberton

Good Confident Necrosis with Professor Mark Emberton

Is it possible to destroy the cancer while preserving the prostate?

Is it possible to destroy the cancer while preserving the prostate?

Prostate cancer: overdiagnosis and unnecessary treatment

Prostate cancer: overdiagnosis and unnecessary treatment

MRI and MRI-directed biopsies for the diagnosis of prostate cancer

MRI and MRI-directed biopsies for the diagnosis of prostate cancer

Is delayed diagnosis in the UK to blame for poorer cancer outcomes?

Is delayed diagnosis in the UK to blame for poorer cancer outcomes?

Areas of expertise

  • Focal therapy
  • Minimally invasive treatment for prostate cancer which aims to preserve prostate and aims to preserve function
  • Non-invasive diagnosis incorporating MRI and targeted biopsies where necessary
  • Use of biomarkers to refine the risk stratification of men who've been recently diagnosed with prostate cancer

Recommendations for Prof. Emberton

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Recommended by:

  • byDr John Paul Horton, GP

    Mark has seen many of my patients with excellent feedback. When I had a concern myself it was Mark I choose to see. As expected I was impressed with his knowledge, empathy and advice.

  • byDr Marita Koumettou, GP

    A really brilliant Urologist with a special interest in prostate cancer care

  • byDr Donald Roy Macgregor, GP

    Previously a psychology graduate. As a urologist, has good people skills.

  • byDr Jane Eleanor Sackville West, GP

    Excellent urologist and good communication to patients and GPs

  • byDr Cristina M Romete, GP

    Excellent clinical knowledge and patient communication skills

  • byDr Philip Joseph Posner, GP

    Very experienced urologist, very positive patient feedback.

  • byDr Bibi Maryam Ghalaie, GP

    Highly experienced, approachable and professional.

  • byDr Ian Benjamin Colvin, GP

    Recommended by my patients

  • byDr Philippa Ruth Kaye, GP

    Recommended urologist

  • byDr Trevor John Yellon, GP

    Recommended urologist

  • byDr Timothy John Gerrard, GP

    For prostatic disease

  • byDr Gemma Claire Bailey, GP

    Recommended urologist

  • byProf. Stuart Bloom, Consultant Gastroenterologist

    An excellent urologist and. He is also very keen on dealing with prostrate cancer.

  • byMr Dan Wood, Urological Surgeon

    Recommended urologist

  • byMr Paul Cathcart, Urological Surgeon

    Recommended Urologist

  • by Mr Hashim Uddin Ahmed, Urologist

    Recommended urologist

  • byDr John Paul Horton, GP

    Mark has seen many of my patients with excellent feedback. When I had a concern myself it was Mark I choose to see. As expected I was impressed with his knowledge, empathy and advice.

  • byDr Marita Koumettou, GP

    A really brilliant Urologist with a special interest in prostate cancer care

  • byDr Donald Roy Macgregor, GP

    Previously a psychology graduate. As a urologist, has good people skills.

  • byDr Jane Eleanor Sackville West, GP

    Excellent urologist and good communication to patients and GPs

  • byDr Cristina M Romete, GP

    Excellent clinical knowledge and patient communication skills

  • byDr Philip Joseph Posner, GP

    Very experienced urologist, very positive patient feedback.

  • byDr Bibi Maryam Ghalaie, GP

    Highly experienced, approachable and professional.

  • byDr Ian Benjamin Colvin, GP

    Recommended by my patients

  • byDr Philippa Ruth Kaye, GP

    Recommended urologist

  • byDr Trevor John Yellon, GP

    Recommended urologist

  • byDr Timothy John Gerrard, GP

    For prostatic disease

  • byDr Gemma Claire Bailey, GP

    Recommended urologist

  • byProf. Stuart Bloom, Consultant Gastroenterologist

    An excellent urologist and. He is also very keen on dealing with prostrate cancer.

  • byMr Dan Wood, Urological Surgeon

    Recommended urologist

  • byMr Paul Cathcart, Urological Surgeon

    Recommended Urologist

  • by Mr Hashim Uddin Ahmed, Urologist

    Recommended urologist

  • Address

    • London Urology Specialists

      King Edward VII’s Hospital, 5 – 10 Beaumont Street, London, W1G 6AA

    • Telephone consultation

      Available for patients, please call to arrange, W1U 5NY

  • University College Hospital

    235 Euston Rd, Fitzrovia, London, NW1 2BU

  • About Prof. Mark Emberton

    GMC number: 3098619

    Year qualified: 1985

    Place of primary qualification: University of London

    Professor Mark Emberton is an Honorary Consultant Urologist at University College Hospitals NHS Foundation Trust, and Founding Pioneer of The Charity Prostate Cancer UK. He is Professor of Interventional Oncology at UCL. He was appointed Dean of UCL Faculty of Medical Sciences in 2015. He specialises in the implementation of new imaging techniques, nanotechnologies, bio-engineering materials and non-invasive treatment approaches, such as high intensity focused ultrasound and photo-dynamic therapy. His clinical research is aimed at improving the diagnostic and risk stratification tools and treatment strategies for prostate cancer (PCa).

    Professor Emberton’s research has been published in more than 300 peer-reviewed scientific papers in journals including BMJ, Lancet Oncology and European Urology. He is also interested in the methodological aspects of clinical research, particularly on the use of alternatives to the randomised control trial in surgery. He has contributed to the development of guidelines for the management of PCa and lower urinary tract symptoms, published by the International Society of Geriatric Oncology and the European Association of Urology. He is a member of various urological and medical organisations including the American Association of GenitoUrinary Surgeons, the British Association of Urological Surgeons and the European Association of Urology). He is a founding Partner of London Urology Associates, and is a Trustee of Prostate Action.

    Areas of expertise

    • Active surveillance
    • Cyrosurgery
    • Focal therapy
    • Focal therapy
    • High intesntivy focused ultrasound
    • Minimally-invasive treatment for prostate cancer, which aims to preserve prostate function
    • MRI scan
    • Non-invasive diagnosis
    • Non-invasive diagnosis incorporating MRI and targeted biopsies where necessary
    • Photo therapy
    • Photo-dynamic therapy
    • Prostate cancer
    • Salvage therapy
    • Use of biomarkers to refine the risk stratification of men who been recently diagnosed with prostate cancer
    • Vascular targeted therapy

    Frequently asked questions

  • What are the common symptoms that your patients tend to present with?

    Patients visit me with prostate problems. Sometimes there are symptoms such as when a man has lower urinary tract symptoms, and at other times, a higher frequency and urgency of urination at night.

    A much more common symptom is patients presenting with a prostate cancer risk or a prostate cancer diagnosis, which is my most frequent consultation. That would be a man with an elevated PSA or a positive family history who wants reassurance in that regard.

    In terms of the treatments that I'm recognised for, we have pioneered the use of MRI in prostate cancer, which is now globally accepted. We have pioneered the use of minimally-invasive therapies, which are increasingly being used around the world. Patients come from all over the world to me to get advice in both these areas.

  • What are the treatments that you're able to offer your patients?

    Possibly, better than any other centre in the world, we are able to offer patients the treatment that is most suited to themselves, their prostates and their prostate cancer. What we do, unlike any other centre in the world, is use a number of energy sources to selectively treat the cancer and preserve the prostate and, therefore, maximise the cure rate whilst also maximising the chances of them having no symptoms or side effects as a result of their treatment.

    We focus on improving the therapeutic ratio for men with early prostate cancer and avoiding, where possible, the use of surgery or radiotherapy.

  • What are your areas of sub-specialist interest?

    I'm a clinician scientist. Half my week is spent doing clinical science and half is spent doing medicine. The two dovetail each other and, therefore, the trials that I do in diagnosis and therapy, we implement in the patients that we treat.

    My laboratory, if we can use the word, is the clinic. It's from there that we recruit patients into Phase I, Phase II and Phase III clinical studies.

    In addition to the above, I also focus on younger patients, young adults or adolescents who present with primary problems that need assessment.

  • Professional memberships

    British Association of Urological Surgeons
    European Association of Urological Surgeons
    Royal College of Surgeons
    General Medical Council

    Other specialists recommended by Prof. Emberton